 |
 |

Laser-Assisted Uvulopalatoplasty for Snoring
Medium- to Long-term Subjective and Objective Analysis
Gilead Berger, MD;
Yehuda Finkelstein, MD;
Gideon Stein, MD;
Dov Ophir, MD
Arch Otolaryngol Head Neck Surg. 2001;127:412-417.
ABSTRACT
 |  |
Objective To assess the subjective and objective medium- to long-term results
of laser-assisted uvulopalatoplasty for snoring.
Design A nonrandomized, prospective, before-after trial.
Subjects and Interventions Fourteen patients underwent laser-assisted uvulopalatoplasty surgery;
2 surgical techniques, which differ with respect to the mode of midline palatal
vaporization, were used.
Main Outcome Measures Subjective analysis included a preoperative and 2 postoperative evaluations
of the state of snoring: 4 weeks and 10.1 ± 7.9 months (mean ±
SD) after completion of last laser treatment. In addition, a score on 5 other
sleep-related symptoms was recorded before treatment and after 10.1 ±
7.9 months; at that time, patients also estimated their overall satisfaction
with the procedure. Objective analysis included preoperative nocturnal polysomnographic
studies that were repeated postoperatively.
Results A decline in snoring improvement from 79% (11/14) to 57% (8/14) was
recorded; furthermore, state of snoring worsened from 7% (1/14) to 21% (3/14).
Likewise, reevaluation of the 5 other sleep-related symptoms at the final
follow-up visit uncovered a 57% improvement rate. Overall satisfaction with
the procedure was 43%. The results of the postoperative objective studies
corresponded to those of the subjective ones and demonstrated significant
worsening of respiratory disturbance index in 3 (21%) of the 14 patients,
who became mildly apneic. These findings were encountered with both laser
techniques.
Conclusions The favorable subjective short-term results of laser-assisted uvulopalatoplasty
deteriorated with time. In addition, postoperative nocturnal polysomnography
showed that the procedure caused mild obstructive sleep apnea in a considerable
number of patients who formerly were nonapneic snorers. These findings may
be related to velopharyngeal narrowing and progressive palatal fibrosis, caused
by the thermal damage inflicted by the laser beam.
INTRODUCTION
SNORING IS a common phenomenon and may be associated with restless sleep,
night awakening, morning fatigue, daytime somnolence, and hypoxemia. Snoring,
even without apnea, can be a risk factor for hypertension, angina pectoris,
cerebral infarction, pulmonary hypertension, and congestive heart failure.1, 2 This has led to the search for a compatible
solution to a socially vexing problem and its potentially life-threatening
pathologic consequences.
Laser-assisted uvulopalatoplasty (LAUP) is considered a popular and
well-received surgical procedure to eliminate snoring and to treat obstructive
sleep apnea (OSA). Reports on the efficacy of the procedure for snoring were
promising, with a clinical success rate ranging from 70% to 95%.3, 4, 5
There is, however, a scarcity of medium- to long-term data regarding the durability
of these favorable results. Wareing and Mitchell,5
Wareing et al,6 and Ellis,7
for example, demonstrated that LAUP was associated with a considerable number
of delayed failures. Furthermore, the available reports included subjective
data to analyze the effectiveness of LAUP for snoring, while postoperative
polysomnography (PSG) has been regularly excluded. This tendency probably
derives from the encouraging results reported for LAUP and the high cost of
the sleep studies. Consequently, the surgeons evaluated the procedure in terms
of whether it eliminated snoring, but lacked information regarding possible
changes in the objective sleep parameters.
This clinical study forms part of a research project conducted on the
late anatomic and histopathologic changes of the soft palate after LAUP8, 9 and was undertaken to assess the efficacy
of the procedure for snoring with regard to (1) the durability of the subjective
results as time progresses and (2) the postoperative objective outcome.
PATIENTS AND METHODS
The study population consisted of 14 patients who had bothersome snoring
and completed LAUP treatment between June 1, 1994, and March 30, 1995, at
the outpatient clinic of Meir General Hospital, Sapir Medical Center, Kfar
Saba, Israel. All patients consented to participate in the study after being
informed of the known benefits, risks, and complications of the procedure.
There were 10 men and 4 women, ranging in age from 40 to 66 years (mean ±
SD, 51.2 ± 7.5 years). They were generally healthy, and their mean
body mass index (calculated as weight in kilograms divided by the square of
height in meters) was 26.7 ± 3.7 (Table 1).
|
|
|
|
Table 1. Anthropometry of the Study Group*
|
|
|
PREOPERATIVE EVALUATION
Patients' and bed partners' detailed histories relevant to upper airway
obstruction were obtained in structured interviews. They were requested to
describe their snoring state and to indicate the absence (0) or existence
(1) of 5 other sleep-related symptoms. The first 3 were addressed to the patients
and the remaining 2 to their bed partners and included (1) night awakening,
(2) morning fatigue, (3) daytime somnolence, (4) episodes of sleep apnea,
and (5) involuntary body movements during sleep. A total score from 0 to 5
was calculated for each patient.
All subjects underwent a complete otolaryngologic examination, including
flexible fiberoptic nasopharyngoscopic examination of the nose, pharynx and
larynx, and had nocturnal PSG with simultaneous electroencephalography, electrocardiography,
electromyography, and surface-electrode electro-oculography. Air flow at the
nose and mouth was monitored with thermistors, and respiratory effort was
assessed with inductive plethysmography. Oxygen saturation was measured with
continuous finger pulse oxymetry. The severity of OSA was expressed in terms
of a respiratory disturbance index (RDI), calculated as the average number
of apneas plus hypopneas per hour of sleep. The study defined patients as
(1) snorers when RDI was 0 to 5, (2) mildly obstructed when RDI was 6 to 20, (3) moderately
obstructed when RDI was 21 to 40, and (4) severely
obstructed when RDI was greater than 40. All patients were categorized
as nonapneic snorers if they had an RDI of 5 or less. Patients were photographed
intraorally by means of a 35-mm camera (Yashica FX-3 Super 2000; Yashica,
Tokyo, Japan), mounted with a medical lens (Yashica 100 DX; Yashica), and
adjusted on a fixed reproduction ratio of two thirds.
SURGICAL METHODS
Two surgical techniques of LAUP were used, differing with respect to
the mode of midline palatal vaporization. Nine patients underwent the first
technique (type 1), in which a focused continuous beam of 15 to 20 W was used
to excise the uvular base, through the full palatal depth, and then extended
bilaterally to the anterior and posterior tonsillar pillars. Serial laser
tonsillectomy was also performed. It was carried out in 1 to 2 sessions, with
a mean of 1.22.
Five patients underwent the second technique (type 2), in which through-and-through
full-thickness vertical trenches were created on the free edge of the soft
palate, on either side of the uvula, at a power setting of 15 to 20 W. With
the use of a SwiftLase scanner (Sharplan Lasers, Inc, Allendale, NJ) attached
to the carbon dioxide laser, as described by Krespi et al,4
the core of the uvula was removed from the bottom up, in a "fishmouth" manner,
while the mucosa of the uvula was preserved. Eventually, the uvula was shortened
and thinned by up to 80% to 90% of its original size. This technique was carried
out in 1 to 2 sessions, with a mean of 1.4.
POSTOPERATIVE EVALUATION
All patients were reexamined 4 weeks and 3.5 to 36 months (mean ±
SD, 10.1 ± 7.9) after completion of the last laser treatment. On both
occasions, they were asked to compare snoring with its preoperative state
and to answer whether it (1) was abolished or markedly reduced, (2) remained
the same, or (3) had worsened. Furthermore, 5 other sleep-related symptoms
were assessed at the end of the follow-up period, and a total score from 0
to 5 (as described earlier) was calculated for each patient. Possible variations
between the preoperative and postoperative score indicated whether patients
(1) improved, (2) remained unchanged, or (3) worsened. They were also asked
to estimate their overall satisfaction with the procedure with a yes-no answer.
The PSG was repeated immediately after the last follow-up visit, at
the same sleep laboratory, with the use of previously determined criteria
for evaluation. All patients were photographed intraorally immediately and
2 weeks and 10.1 ± 7.9 months after last laser treatment.
STATISTICAL ANALYSIS
Measurements were expressed as mean ± SD. Comparisons were performed
by paired t test and nonparametric Mann-Whitney test.
Probability values of P<.05 were considered significant.
RESULTS
SUBJECTIVE ASSESSMENT
Table 2 compares the changes
in snoring state and the score of each patient in the 5 other sleep-related
symptoms. During the interval between follow-up visits, improvement in snoring
declined from 79% (11/14) to 57% (8/14), and worsening in snoring increased
from 7% (1/14) to 21% (3/14). Analysis of the 5 other sleep-related symptoms
at the final follow-up showed a similar success rate (57%). One patient had
deterioration of symptoms in this respect. Patients' overall satisfaction
with LAUP, which was also assessed at the last follow-up visit, established
that only 6 patients (43%) were satisfied, while the remaining 8 (57%) were
dissatisfied and reluctant to go through the procedure again.
|
|
|
|
Table 2. Changes in the State of Snoring and in the 5 Sleep-Related
Symptoms
|
|
|
OBJECTIVE ANALYSIS
Table 3 compares the objective
findings recorded before treatment and at the conclusion of the follow-up.
The mean preoperative and postoperative RDI of the patients was 3.4 ±
2.1 vs 5.0 ± 4.4, and the difference between the 2 figures was not
statistically significant. Nevertheless, the postoperative RDI in 3 patients
(patients 6, 9, and 12) deteriorated considerably, with a new score compatible
with mild OSA. Statistical analysis confirmed that the change of the RDI in
these patients was significantly greater (P<.001)
than in the remaining 11 patients, indicating that the former underwent a
tangible worsening of their status as a result of laser treatment. Thus, 21%
(3/14) of the patients who initially were snorers worsened and developed mild
apnea, regardless of the type of laser surgery (Table 1 and Table 3).
No weight gain was observed among these patients, and their postoperative
body mass index remained unchanged. In 2 patients (patients 9 and 12), the
objective deterioration of RDI was consistent with the subjective aggravation
of snoring, while in patient 6 they were inconsistent. An additional 4 patients
(patients 1, 8, 10, and 13) also had a minor decline in their sleep parameter.
|
|
|
|
Table 3. Objective Results of LAUP in Nonapneic Snorers*
|
|
|
The mean lowest oxygen saturation did not differ significantly between
preoperative and postoperative measurements (92.3% ± 5.9% vs 92.9%
± 5.4%). Yet, in 1 patient (patient 12), there was a significant lowering
of postoperative lowest oxygen saturation, from 100% to 83%, that was consistent
with the RDI elevation from 0 to 11.
Intraoral photographs demonstrated that the oropharyngeal isthmus, which
was substantially enlarged immediately after surgery, was reduced in all patients
at the end of the follow-up period. After type 1 procedures, this reduction
was related to a curtainlike medial traction of the posterior pillars and
a pulling of the lateral pharyngeal walls medially (Figure 1). After type 2 procedures, the mechanism was linked to
a progressive approximation of the tonsillar pillars from the upper narrowest
part of the vertical trench in a zipperlike manner,8
leading to posterior traction of the velum and medial traction of the lateral
pharyngeal walls (Figure 2).
|
|
|
|
Figure 1. Preoperative and postoperative
intraoral photographs of a patient who underwent type 1 laser-assisted uvulopalatoplasty.
A, Preoperative view. B, Immediate postoperative view. C, Late postoperative
view; note severe medial curtainlike traction of the posterior pillars (white
arrows).
|
|
|
|
|
|
|
Figure 2. Preoperative and postoperative
intraoral photographs of a patient who underwent type 2 laser-assisted uvulopalatoplasty.
A, Preoperative view. B, Two weeks after treatment, the healing process is
in progress and the zipper phenomenon takes place (black arrows). C, Late
postoperative view; note that the zipper is completed, leaving 2 white longitudinal
scars (black arrows). The shortened posterior pillars are now retracted, pulling
the velum posteriorly (white arrows).
|
|
|
COMPLICATIONS AND ADVERSE EFFECTS
There were no major complications, including postoperative hemorrhage.
The most common adverse effect of LAUP was pain that lasted from 5 to 14 days
(mean, 9.7 ± 3.5 days) postoperatively and was severe enough to keep
patients away from work for 4.5 ± 3.1 days. Five patients (36%) complained
of persistent throat dryness or itching; in addition, 3 patients (21%) exhibited
difficulty in nasal breathing, of whom 1 had a preexisting nasal obstruction.
COMMENT
According to its advocates, LAUP represents a significant improvement
over uvulopalatopharyngoplasty (UPPP), which has an 86% success rate for treatment
of snoring10 but is not without morbidity and
troublesome complications.11 This less radical
alternative is a bloodless office procedure, carried out under local anesthesia,
and has a low complication rate. Being mostly performed in stages, it is well
controlled and allows optimal tissue removal benefit, with minimal danger
of overexcision. Also, it is considered a low-cost procedure compared with
UPPP.12 Data showed that the success rate of
LAUP for the treatment of snoring was comparable with or exceeded that of
UPPP. Nevertheless, the follow-up period was not recorded in previous studies3, 4 or was based on a short period ranging
from 4 to 6 weeks.12, 13, 14
Our subjective data concerning the state of snoring reaffirmed that
the initial results were encouraging (79% success rate) and compatible with
those reported by other investigators.5 This
may imply that our technique and surgical skills are similar to those in other
studies and that LAUP is universally associated with early favorable results.
Our series, however, demonstrated that, at the end of the follow-up period,
improvement of snoring was found only in 57% of the patients. In addition,
analysis of the 5 other sleep-related symptoms, done at the final visit, also
showed only a 57% improvement rate. Wareing and Mitchell5
and Wareing et al6 pointed out that, similar
to UPPP,15 LAUP was also associated with delayed
failures in a sizable number of patients. Not only did the failure rate in
snoring double between 1 and 6 months postoperatively, but evaluation of the
same cohort 24 months after operation disclosed a further decline, with reappearance
of socially disruptive snoring in one fifth of the patients who earlier were
considered to have benefited from the procedure. Consequently, the overall
success rate at this time was 55%. Likewise, Ellis7
reported early good snoring control in 14 of 16 patients but observed a further
relapse in 3 patients 18 months postoperatively. Thus, the data cited above
suggest that, in the long run, patients exhibit a decline in the success rate
of LAUP.
Of interest is the source of the 14% gap between the rates of symptom
improvement (57%) and patients' satisfaction with the procedure (43%). A question
is raised as to why some of the patients, who benefited from laser treatment
with respect to elimination of snoring, morning fatigue, daytime somnolence,
restless sleep, etc, remained dissatisfied. The severe and prolonged pain
these patients had suffered may have overshadowed symptom improvement. Indeed,
the most common postoperative adverse effect in the present study was pain,
which lasted up to 14 days and was severe enough to keep patients away from
work for an average of 4.5 days. Wareing and Mitchell5
also dealt with the issue and found that only 74% (25/34) of the patients
who were satisfied with the procedure would be willing to go through it again
because of pain and other side effects.
The results of the present study showed that, in addition to a diminished
rate of snoring control, there was actual worsening of symptoms and signs
in a fairly large proportion of the patients. Thus, at the end of the follow-up
period, more than one fifth of them (21%) showed subjective aggravation of
their initial snoring state. Furthermore, postoperative PSG performed at the
same time demonstrated that 3 patients whose former RDI was 5, 5, and 0 underwent
a significant worsening of their status and became mildly apneic, with an
RDI of 15, 10.1, and 11, respectively. Three articles have recently reported
the same finding.16, 17, 18
Lauretano et al16 examined the efficacy of
LAUP in 12 snorers and performed postoperative sleep studies in 3 of them.
Measurements were statistically insignificant, but they showed more than a
2-fold increase in the mean RDI (4.2 vs 9.3). Walker et al17
found a 23.7% deterioration of RDI after LAUP, from the mildest to the more
severe degrees of OSA. Ryan and Love18 studied
the efficacy of LAUP in 44 patients with symptomatic mild to moderate OSA.
Polysomnography performed before and at least 3 months after surgery showed
a significant worsening of RDI in 30% of the patients. Hence, it is thought
that, since laser treatment aggravated OSA in apneic patients, the same could
apply to snorers.
Postoperative PSG has usually been excluded from the studies of LAUP
for snoring. The reasons to omit these tests from the agenda probably lie
in the high cost of the nocturnal studies and the remarkable success rate
of previous evaluations, which were based on a short follow-up period. Our
work showed that PSG was an indispensable tool to examine the sequelae of
LAUP for snoring, as it uncovered deterioration of breathing parameters, namely,
de novo precipitation of OSA. This trend was observed in both types of laser
surgery. However, because of our small sample size, the data presented herein
should be interpreted with caution, and further study to confirm these findings
is warranted.
Another form of thermal energy was also associated with aggravation
of objective sleep parameters. Coleman and Smith19
assessed the safety and efficacy of radiofrequency tissue reduction of the
palate for the treatment of snoring and mild sleep-disordered breathing, and
their study showed an elevation of postoperative RDI in 6 of the 12 patients
enrolled in the study; 2 of them, who were classified as snorers, developed
mild obstructive sleep apnea (from 0 to 9 and from 4 to 9).
The late decline in the subjective results and the development of OSA
in our series are probably attributable to the progressive fibrosis inflicted
on soft palate tissues by thermal damage from the laser beam. Laser-assisted
uvulopalatoplasty, which is based on cutting and vaporizing palatal tissues,
leaves a raw surface that subsequently undergoes scarring. These wounds take
longer to heal than those created with a scalpel.20
The effectiveness of surgery, therefore, should be assessed months later,
when the healing process has stabilized. Indeed, Berger et al9
have recently reported the long-term histopathologic changes after LAUP. They
found that various components of the soft palate underwent extensive and progressive
changes, which increased with every additional treatment. The loose connective
tissue present in the lamina propria was replaced by diffuse fibrosis. These
changes also extended to the central layer, on the expanse of seromucous glands
and muscle fibers. The authors also found that the nature and extent of thermal
damage to the palate by horizontal incision across the palate (type 1) or
by vertical trenches and trimming of the uvula (type 2) resulted in similar
pathologic changes. Palatal fibrosis after LAUP was clinically encountered
in 27% of the patients in Carenfelt's study.21
Furthermore, Finkelstein et al8 ascertained
that pharyngeal scar contracture occurred in the centripetal direction and
caused medial traction of the posterior pillars, or even of the lateral pharyngeal
walls. Eventually, the pharyngeal cross-sectional area went through major
anatomic changes, with narrowing of the lumen, increased rigidity, decreased
compliance, and loss of distensibility needed during inspiration. All of these
deficiencies presumably have deleterious effects on the respiratory dynamics
and may trigger the generation of OSA.
As previously described, LAUP is in most cases a staged procedure, requiring
several sessions to achieve significant reduction of snoring and reversal
of daytime sleepiness. Several authors addressed the issue of the number of
treatments in snorers and in apneic patients. Dickson and Mintz13
used a technique that resembled our description of type 1 and recommended
only 1 stage of LAUP. Other researchers performed the "classic" procedure
and used a technique resembling our description of type 2. Krespi et al4 advocated 2 to 3 sessions for snorers and 4 to 5 for
apneic patients; likewise, Walker et al12 used
a mean of 2.6 sessions for snorers compared with 3.8 for apneic patients.
Wareing and Mitchell5 did not expand on the
number of procedures they used, yet they discussed the various principles
that dictated the completion of treatment, ie, disappearance of snoring, patients'
refusal to continue surgery, and the removal of an adequate amount of palatal
tissue in previous laser surgery that rendered further trimming unsafe. Nine
of our patients were operated on by a method similar to Dickson and Mintz's13 technique (type 1), with a mean of 1.22 applications.
The other 5 underwent type 2 technique, with a mean number of 1.4 applications.
No patient had more than 2 sessions, as almost 80% of them were initially
satisfied with their snoring control. In addition, some refused further therapy
because of severe pain; others showed signs of fibrosis and progressive narrowing
of the velopharyngeal isthmus in a zipperlike manner as early as 2 weeks after
treatment.8
The human uvula and the posterior portion of the soft palate harbor
numerous seromucous glands that provide continuous lubrication to the oropharynx
and probably to the vocal cords.22 Therefore,
any surgical intervention that diminishes the amount of glandular tissue may
culminate in pharyngeal dryness and surface irritation of the vocal cords.
Indeed, LAUP is associated with a marked decrease in the amount and function
of velar glands because of extensive palatal fibrosis and glandular destruction;
consequently, 5 (36%) of our patients had annoying pharyngeal dryness and
discomfort at the end of the follow-up. Similarly, patients who underwent
UPPP had a sensation of dryness in the throat and speech articulation disorders.11, 23, 24 Salas-Provance and
Kuehn,23 for instance, ascribed the changes
in the voice quality to pharyngeal dryness.
Appearance or worsening of nasal breathing difficulty was recorded in
3 patients (21%). This late complication may be related to the progressive
palatal fibrosis and its concomitant velopharyngeal narrowing,8, 9
which hampers the airflow and increases airway resistance in a retrograde
fashion from this segment up to the nose. Although the nasal passages are
patent, a sensation of blockage ensues because of respiration under abnormal
air pressure.
CONCLUSIONS
The data are based on a small number of cases, and the sequelae of LAUP
surgery for snoring deserve further investigation. Nevertheless, the study
demonstrated that (1) the subjective short-term results were favorable, but
with the passage of time, improvement in snoring deteriorated; (2) the procedure
may lead to mild OSA in a considerable number of patients; (3) postoperative
PSG was necessary to assess the objective results of the procedure; (4) the
oropharyngeal isthmus, which was markedly enlarged after surgery, narrowed
at the end of the follow-up period; (5) both techniques of surgery were associated
with similar clinical outcomes; and (6) dryness of the throat was not an uncommon
phenomenon.
The full implications of the procedure are yet to be established; hence,
the decision to perform LAUP for snoring should be approached with caution.
AUTHOR INFORMATION
Accepted for publication September 5, 2000.
David Wexler, MD, Department of OtolaryngologyHead and Neck Surgery,
Meir General Hospital, Sapir Medical Center, Kfar Saba, Israel, reviewed the
manuscript and provided helpful suggestions. Rachel Berger provided writing
and editing assistance.
From the Department of OtolaryngologyHead and Neck Surgery (Drs
Berger, Stein, and Ophir) and the Palate Surgery Unit (Dr Finkelstein), Meir
General Hospital, Sapir Medical Center, Kfar Saba, Israel; and the Sackler
School of Medicine, Tel-Aviv University, Tel-Aviv, Israel (Drs Berger, Finkelstein,
Stein, and Ophir).
Corresponding author and reprints: Gilead Berger, MD, Department
of OtolaryngologyHead and Neck Surgery, Meir General Hospital, Sapir
Medical Center, Kfar Saba 44281, Israel (e-mail: berger-g{at}zahav.net.il).
REFERENCES
 |  |
1. Partinen M, Palomaki H. Snoring and cerebral infarction. Lancet. 1985;2:1325-1326.
ISI
| PUBMED
2. Koskenvuo M, Kaprio J, Telakivi T, Partinen M, Heikkila K, Sarna S. Snoring as a risk factor for ischaemic heart disease and stroke in
men. Br Med J (Clin Res Ed). 1987;294:16-19.
3. Kamami YV. Outpatient treatment of snoring with CO2 laser: laser-assisted
UPPP. J Otolaryngol. 1994;23:391-394.
ISI
| PUBMED
4. Krespi YP, Keidar A, Khosh MM, Pearlman SJ, Zammit G. The efficacy of laser-assisted uvulopalatopharyngoplasty in the management
of obstructive sleep apnea and upper airway resistance syndrome. Operative Techniques Otolaryngol Head Neck Surg. 1994;5:235-243.
5. Wareing M, Mitchell D. Laser-assisted uvulopalatoplasty: an assessment of a technique. J Laryngol Otol. 1996;110:232-236.
ISI
| PUBMED
6. Wareing MJ, Callanan VP, Mitchell DB. Laser assisted uvulopalatoplasty: six and eighteen month results. J Laryngol Otol. 1998;112:639-641.
ISI
| PUBMED
7. Ellis PDM. Laser palatoplasty for snoring due to palatal flutter: a further report. Clin Otolaryngol. 1994;19:350-351.
FULL TEXT
|
ISI
| PUBMED
8. Finkelstein Y, Shapiro-Feinberg M, Stein G, Ophir D. Uvulopalatopharyngoplasty versus laser-assisted uvulopalatoplasty:
anatomic considerations. Arch Otolaryngol Head Neck Surg. 1997;123:265-276.
FREE FULL TEXT
9. Berger G, Finkelstein Y, Ophir D. Histopathologic changes of the soft palate following laser-assisted
uvulopalatoplasty. Arch Otolaryngol Head Neck Surg. 1999;125:786-790.
FREE FULL TEXT
10. Katsantonis GP, Friedman WH, Rosenblum BN, Walsh JK. The surgical treatment of snoring: a patient's perspective. Laryngoscope. 1990;100:138-140.
ISI
| PUBMED
11. Croft CB, Golding-Wood DG. Uses and complications of uvulopalatopharyngoplasty. J Laryngol Otol. 1990;104:871-875.
ISI
| PUBMED
12. Walker RP, Grigg-Damberger MM, Gopalsami C, Totten MC. Laser-assisted uvulopalatoplasty for snoring and obstructive sleep
apnea: results in 170 patients. Laryngoscope. 1995;105:938-943.
ISI
| PUBMED
13. Dickson RI, Mintz DR. One-stage laser-assisted uvulopalatoplasty. J Otolaryngol. 1996;25:155-161.
ISI
| PUBMED
14. Mickelson SA. Laser-assisted uvulopalatoplasty for obstructive sleep apnea. Laryngoscope. 1996;106:10-13.
FULL TEXT
|
ISI
| PUBMED
15. Macnab T, Blokmanis A, Dickson RI. Long-term results of uvulopalatopharyngoplasty for snoring. J Otolaryngol. 1992;21:350-354.
ISI
| PUBMED
16. Lauretano AM, Khosla RK, Richardson G, et al. Efficacy of laser-assisted uvulopalatoplasty. Lasers Surg Med. 1997;21:109-116.
FULL TEXT
|
ISI
| PUBMED
17. Walker RP, Grigg-Damberger MM, Gopalsami C. Laser-assisted uvulopalatoplasty for the treatment of mild, moderate,
and severe obstructive sleep apnea. Laryngoscope. 1999;109:79-85.
FULL TEXT
|
ISI
| PUBMED
18. Ryan CF, Love LL. Unpredictable results of laser-assisted uvulopalatoplasty in the treatment
of obstructive sleep apnea. Thorax. 2000;55:399-404.
FREE FULL TEXT
19. Coleman SC, Smith TL. Midline radiofrequency tissue reduction of the palate for bothersome
snoring and sleep-disorder breathing: a clinical trial. Otolaryngol Head Neck Surg. 2000;122:387-394.
FULL TEXT
|
ISI
| PUBMED
20. Schünke M, Kruss C, Mecke H, Werner JA. Characteristic features of wound healing in laser-induced incisions. Adv Otorhinolaryngol. 1995;49:8-14.
PUBMED
21. Carenfelt C. Laser uvulopalatoplasty in treatment of habitual snoring. Ann Otol Rhinol Laryngol. 1991;100:451-454.
ISI
| PUBMED
22. Finkelstein Y, Meshorer A, Talmi YP, Brenner Y, Gal R, Zohar Y. The riddle of the uvula. Otolaryngol Head Neck Surg. 1992;107:444-450.
ISI
| PUBMED
23. Salas-Provance MB, Kuehn DP. Speech status following uvulopalatopharyngoplasty. Chest. 1990;97:111-117.
FREE FULL TEXT
24. Koay CB, Freeland AP, Stradling JR. Short- and long-term outcomes of uvulopalatopharyngoplasty. Clin Otolaryngol. 1995;20:45-48.
FULL TEXT
|
ISI
| PUBMED
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED ARTICLE
Archives of OtolaryngologyHead & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2001;127(4):470.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Laser-assisted uvulopalatoplasty for snoring: does it meet the expectations?
Larrosa et al.
Eur Respir J 2004;24:66-70.
ABSTRACT
| FULL TEXT
Is There a Better Way to Do Laser-Assisted Uvulopalatoplasty?
Berger et al.
Arch Otolaryngol Head Neck Surg 2003;129:447-453.
ABSTRACT
| FULL TEXT
LAUP Reconsidered--Reply
Berger
Arch Otolaryngol Head Neck Surg 2003;129:495-495.
FULL TEXT
A Randomized Trial of Laser-assisted Uvulopalatoplasty in the Treatment of Mild Obstructive Sleep Apnea
Ferguson et al.
Am. J. Respir. Crit. Care Med. 2003;167:15-19.
ABSTRACT
| FULL TEXT
Laser-Assisted Uvulopalatoplasty for the Management of Obstructive Sleep Apnea: Myths and Facts
Finkelstein et al.
Arch Otolaryngol Head Neck Surg 2002;128:429-434.
ABSTRACT
| FULL TEXT
Response to Laser-Assisted Uvuloplasty for Snoring
Hausner and Berger
Arch Otolaryngol Head Neck Surg 2002;128:92-93.
FULL TEXT
|